Urine Collection and Novel UTI Biomarkers in Children and Older Adults
COLLECT-UTI
Urine COLLECTion and Novel UTI Biomarkers in Children and Older Adults (COLLECT - UTI)
1 other identifier
observational
230
1 country
1
Brief Summary
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. In non-toilet-trained children, non-invasive urine collection methods are associated with high contamination rates. In older adults, asymptomatic bacteriuria (ASB) is common and complicates interpretation of urine culture results. As UTIs are a leading cause of sepsis in both groups, this diagnostic uncertainty contributes to overdiagnosis and overtreatment. COLLECT-UTI aims to improve UTI diagnostics by evaluating novel urinary host and bacterial markers to distinguish true UTI from contaminated samples in children and from ASB in older adults. The COLLECT-UTI study is a prospective observational study of children under 5 years of age and adults aged 65 years and over undergoing testing for suspected urinary tract infection (UTI). The study will recruit approximately 230 participants in total. Clinical features, laboratory results and 14-day outcomes will be recorded on an electronic case report form (CRF) and REDCap database. Residual urine samples collected during routine clinical care will be used to investigate novel urinary host biomarkers and bacterial markers to improve the diagnosis of UTI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2026
CompletedFirst Posted
Study publicly available on registry
August 14, 2026
CompletedStudy Start
First participant enrolled
August 17, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2028
Study Completion
Last participant's last visit for all outcomes
August 17, 2029
August 14, 2026
August 1, 2026
2 years
August 7, 2026
August 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of urinary host biomarkers for paediatric UTI
The diagnostic performance of urinary host biomarkers for paediatric UTI will be evaluated against the reference standard urine culture. Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) will be calculated, with diagnostic performance also compared across urine collection methods.
14 days from attendance
Molecular characterisation of paediatric urine samples
Molecular analyses will be performed to identify biological signatures associated with different urine sample classifications, including confirmed UTI, contaminated samples and, where available, healthy controls.
14 days from attendance
Molecular characterisation of urine samples from older adults
Molecular analyses will be performed to identify biological signatures associated with symptomatic UTI and asymptomatic bacteriuria.
14 days from attendance
Eligibility Criteria
Children under 5 years olds and older adults aged 65 years and over, attending the Royal Victoria Hospital Emergency Departments who are undergoing routine clinical investigation for suspected urinary tract infection.
You may qualify if:
- Children:
- Children under 5 years of age who are not toilet trained.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
- Older Adults:
- Adults aged 65 years and over.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
You may not qualify if:
- Consent declined.
- Inability to obtain informed consent.
- Antibiotic treatment within the previous 48 hours for acute infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen's University Belfast
Belfast, Northern Ireland, BT9 7BL, United Kingdom
Biospecimen
Urine samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
August 7, 2026
First Posted
August 14, 2026
Study Start (Estimated)
August 17, 2026
Primary Completion (Estimated)
August 17, 2028
Study Completion (Estimated)
August 17, 2029
Last Updated
August 14, 2026
Record last verified: 2026-08